| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |